Sympathetic nervous system regulation of the tumour microenvironment

SW Cole, AS Nagaraja, SK Lutgendorf… - Nature Reviews …, 2015 - nature.com
The peripheral autonomic nervous system (ANS) is known to regulate gene expression in
primary tumours and their surrounding microenvironment. Activation of the sympathetic …

The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies

SK Daniel, YD Seo, VG Pillarisetty - Seminars in cancer biology, 2020 - Elsevier
Single agent checkpoint inhibitor therapy has not been effective for most gastrointestinal
solid tumors, but combination therapy with drugs targeting additional immunosuppressive …

Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma

SK Daniel, KM Sullivan, KP Labadie… - Clinical and translational …, 2019 - Springer
Pancreatic ductal adenocarcinoma (PDA) is a lethal disease with limited response to
cytotoxic chemoradiotherapy, as well as newer immunotherapies. The PDA tumor …

The PDAC extracellular matrix: a review of the ECM protein composition, tumor cell interaction, and therapeutic strategies

VM Perez, JF Kearney, JJ Yeh - Frontiers in oncology, 2021 - frontiersin.org
Pancreatic ductal adenocarcinoma (PDAC) is notorious for a dense fibrotic stroma that is
interlaced with a collagen-based extracellular matrix (ECM) that plays an important role in …

CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy

A Mousavi - Immunology Letters, 2020 - Elsevier
Chemokines are small molecules called “chemotactic cytokines” and regulate many
processes like leukocyte trafficking, homing of immune cells, maturation, cytoskeletal …

Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy

RL Sleightholm, BK Neilsen, J Li, MM Steele… - Pharmacology & …, 2017 - Elsevier
Chemokine networks regulate a variety of cellular, physiological, and immune processes.
These normal functions can become appropriated by cancer cells to facilitate a more …

Strategies for increasing pancreatic tumor immunogenicity

BA Johnson III, M Yarchoan, V Lee, DA Laheru… - Clinical Cancer …, 2017 - AACR
Immunotherapy has changed the standard of care for multiple deadly cancers, including
lung, head and neck, gastric, and some colorectal cancers. However, single-agent …

Cellular and molecular mechanisms of perineural invasion of pancreatic ductal adenocarcinoma

J Li, R Kang, D Tang - Cancer Communications, 2021 - Wiley Online Library
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignant disease with a
unique tumor microenvironment surrounded by an interlaced network of cancer and …

[HTML][HTML] CXCL10 and CCL21 promote migration of pancreatic cancer cells toward sensory neurons and neural remodeling in tumors in mice, associated with pain in …

M Hirth, J Gandla, C Höper, MM Gaida, N Agarwal… - Gastroenterology, 2020 - Elsevier
Background & Aims Pancreatic ductal adenocarcinoma (PDAC) is frequently accompanied
by excruciating pain, which has been associated with attraction of cancer cells and their …

[HTML][HTML] Perineural invasion-associated biomarkers for tumor development

Q Liu, Z Ma, Q Cao, H Zhao, Y Guo, T Liu, J Li - Biomedicine & …, 2022 - Elsevier
Perineural invasion (PNI) is the process of neoplastic invasion of peripheral nerves and is
considered to be the fifth mode of cancer metastasis. PNI has been detected in head and …